IFIH1 and clinically amyopathic dermatomyositis: Initially suspected of having COVID-19, laboratory results showed a negative COVID-19 test but positive anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5), leading to a diagnosis of CADM.